NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/18/2025
Back to search
Official data from USPTO
C CANCER RESEARCH HORIZONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079357872Class
1, 5, 10, 35, 36, 41, 42, 45
Filing
79357872
Registration
7256888
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
12/19/2025
Trademark type
Combined
Nice classes
1, 5, 10, 35, 36, 41, 42, 45
Filing date
07/05/2022
Registration date
01/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/02/2024
Last transaction
12/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
GB
Examiner
RIEPEL,CHRISTINA MAXINE
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the literal elements "C CANCER RESEARCH HORIZONS" on a navy blue background, "CANCER RESEARCH HORIZONS" in white and "C" formed from an array of circles appearing in grey, royal blue, sky blue, and white.
Holders and representatives
Holders
Cancer Research Technology Limited
Representatives
David J. Hrina Brennan, Manna & Diamond, LLC
Technical classification
Nice Classes
Class 1Class 5Class 10Class 35Class 36Class 41Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in the pharmaceutical researchdevelopment or manufacturing industry; chemical preparations for use in the manufacture of pharmaceuticals; cultures of cell media for scientific and research use; media for cell culture for laboratory use in the biotechnological industry; media for cell culture for use in non-medical research laboratories; media for cell culture for use in medical research laboratories
Class 5
Pharmaceutical products for the diagnosisprevention or treatment of cancer; cultures of cell media for medical and veterinary use; living cells for medical or veterinary use
Class 10
Medical apparatus and instrumentsnamely for the diagnosisprevention or treatment of cancer; surgical apparatus and instruments; diagnostic apparatus for medical purposes for the diagnosis or prevention of cancer
Class 35
promotion and advertising of products and services for others for the treatment of cancer; marketing of products and services for others for the treatment of cancer; business project management; business intermediary services in the nature of connecting buyers and sellers for the sale and purchase of goods and services for the treatment of cancer; business information services; providing an on-line commercial information directory for products and services for the treatment of cancer; providing advertising information featuring goods and services of others for the treatment of cancer via an on-line searchable database; business advisory services relating to the commercialisation of products and services for the treatment of cancer
Class 36
Charitable fundraising; Charitable collections in the nature of charitable fundraising; Organisation of charitable collections in the nature of charitable fundraising; charitable fundraising services by means of organisation of fundraising activities and events to support cancer research; providing financial grants for the purpose of researchdiagnosistreatment and prevention of cancer
Class 41
Organisation of community sporting and cultural events; arranging and conducting of conferences and seminars in the field of cancer preventiondiagnosis and treatment; education servicesnamely coursesseminarsworkshops and conferences featuring subject matter related to alleviationdiagnosisprevention and treatment of cancer; the publication of bookstexts and magazines; developing and conducting educational programs in the fields of healthdietnutritioncancer and cancer prevention
Class 42
Scientific and medical research services; providing medical and scientific research information relating to alleviationdiagnosisprevention and treatment of cancer; Conducting research in the fields of healthdietnutritioncancer and cancer prevention; conducting clinical trials for others in the field of oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; biomedical research services; laboratory research services relating to cancer and diagnosisprevention or treatment thereof; medical research in the field of oncology; scientific advisory services relating to chemical reagents; scientific advisory services relating to biological reagents; Clinical or medical laboratory services relating to the production of monoclonal antibodies; laboratory research in the field of gene expression
Class 45
Licensing of intellectual property; licensing of intellectual property for use in the treatment of cancer
Publications
History of USPTO decisions and trademark events.
30 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/30/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/09/2024
FIMP
FINAL DISPOSITION PROCESSED
04/09/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/02/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/02/2024
GPNX
NOTIFICATION PROCESSED BY IB
10/17/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/17/2023
PUBO
PUBLISHED FOR OPPOSITION
10/17/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/27/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/08/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
09/08/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/08/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
09/08/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/29/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/28/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/28/2023
RFNT
REFUSAL PROCESSED BY IB
07/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/10/2023
RFRR
REFUSAL PROCESSED BY MPU
06/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/26/2023
CNRT
NON-FINAL ACTION WRITTEN
04/25/2023
DOCK
ASSIGNED TO EXAMINER
04/19/2023
MAFR
APPLICATION FILING RECEIPT MAILED
12/23/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/19/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/17/2022
Continuous trademark protection
Get notified about every new filing that threatens C CANCER RESEARCH HORIZONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.